Akero Therapeutics, Inc. logo

Akero Therapeutics, Inc. (AKRO)

Delisted
9 Dec 2025
NASDAQ (NGS) NASDAQ (NGS)
$
54. 65
0
0%
$
4.47B Market Cap
- P/E Ratio
- Div Yield
11.61M Volume
-2.84 Eps
$ 54.65
Previous Close
Investors:
Day Range
54.52 54.65
Year Range
21.34 58.4
Want to track AKRO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Akero Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
SY
Sharon York Springhill Fund Asset Management (HK) Co. Ltd.
19,925 $554,313.5 $554,313.5 - -
VT
Vincent Tortorella Point72 (DIFC) Ltd
3,693 $175,328 $175,343.64 $15.64 0.01%